/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

P

Parameswaran Hari

Froedtert Hospital(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

916

Papers

26.6K

Citations

79

h-index

352

i10-index

Parameswaran Hari is an academic researcher from Froedtert Hospital. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Hematopoietic Stem Cell Transplantation & CAR-T cell therapy research. The author has an h-index of 79, co-authored 779 publications.

ORCID: 0000-0002-8800-297X

Research Topics

Multiple Myeloma Research and Treatments Hematopoietic Stem Cell Transplantation CAR-T cell therapy research Protein Degradation and Inhibitors Chronic Lymphocytic Leukemia Research

Papers by this author

works

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

2021 · The Lancet · 1,543 citations

https://doi.org/10.1016/s0140-6736(21)00933-8

Jesús G. Berdeja Deepu Madduri Saad Z. Usmani Andrzej Jakubowiak

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

2022 · Journal for ImmunoTherapy of Cancer · 285 citations

https://doi.org/10.1136/jitc-2022-005755

Jason Chesney Karl D. Lewis Harriet M. Kluger Omid Hamid

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

2021 · The Lancet Oncology · 257 citations

https://doi.org/10.1016/s1470-2045(20)30756-7

Philippe Moreau Shaji Kumar Jesús F. San Miguel Faith E. Davies

Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies

2019 · Frontiers in Oncology · 170 citations

https://doi.org/10.3389/fonc.2019.00146

Nirav N. Shah Theresa Maatman Parameswaran Hari Bryon D. Johnson

Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning

2008 · Biology of Blood and Marrow Transplantation · 162 citations

https://doi.org/10.1016/j.bbmt.2007.11.004

Parameswaran Hari Jeanette Carreras Mei-Jie Zhang Robert Peter Gale

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

2015 · Biology of Blood and Marrow Transplantation · 142 citations

https://doi.org/10.1016/j.bbmt.2015.10.005

Mohamed Shanavas Uday Popat Laura C. Michaelis Veena Fauble

Research topics

topics

Multiple Myeloma Research and Treatments

Hematopoietic Stem Cell Transplantation

CAR-T cell therapy research

Protein Degradation and Inhibitors

Chronic Lymphocytic Leukemia Research

Chat about Author

Papers

Chat

Click to start Chat